Idebenone Catalog No.:M9526-2 and AKT in MDA-MB-453 cells

and AKT in MDA-MB-453 cells

Nafamostat mesilate (1-10 mg/kg) produces the dose-dependent inhibition of scratching induced by intradermal compound 48/80 (10 mg/site)

InChi: InChI=1S/C15H10FNO3/c1-2-8-5-10(18)7-12-14(8)20-15(17-12)9-3-4-13(19)11(16)6-9/h2-7

CAS Number: 222989-99-3

Y Hagihara

Idebenone Catalog No.:M9526-2 and AKT in MDA-MB-453 cellsIdebenone, also known as CV 2619, ss a drug that was initially developed by Takeda Pharmaceutical Company for the treatment of Alzheimer's disease and other cognitive defects. As of December 2013 the drug is not approved for these indications in North America or Europe, but it is approved for the treatment of Leber's hereditary optic neuropathy (LHON) in Europe. Product information CAS Number: 58186 27 9 Molecular Weight: 338. 44 Formula: C19H30O5